Your browser doesn't support javascript.
loading
Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor.
Zhang, Jian; McAndrew, Nicholas P; Wang, Xiaojia; Du, Yiqun; DiCarlo, Brian; Wang, Mei; Chen, Kan; Yu, Wenlei; Hu, Xichun.
Afiliación
  • Zhang J; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • McAndrew NP; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Wang X; Division of Hematology/Oncology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
  • Du Y; Zhejiang Cancer Hospital, Zhejiang, People's Republic of China.
  • DiCarlo B; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Wang M; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Chen K; Division of Hematology/Oncology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
  • Yu W; Dizal Pharmaceutical, Shanghai, People's Republic of China.
  • Hu X; Dizal Pharmaceutical, Shanghai, People's Republic of China.
Breast Cancer Res ; 25(1): 81, 2023 07 06.
Article en En | MEDLINE | ID: mdl-37415239
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias del Sistema Nervioso Central Límite: Animals / Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias del Sistema Nervioso Central Límite: Animals / Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article